Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health

February 16, 2018
Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma

Roche has announced it is to acquire privately held healthcare and technology firm Flatiron Health for $1.9 billion to leverage …

News
flu

New flu med can destroy influenza virus in one day

February 13, 2018
Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical

Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …

News

NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma

February 12, 2018
Sales and Marketing Gazyvaro, NHS, NICE, Roche, follicular lymphoma

Roche has announced that NICE has issued its final decision to recommend the use of its Gazyvaro (obinutuzumab). The glyco-engineered …

News
array_biopharma

Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018
Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …

News
roche_glass_building

NICE approves Perjeta for routine use on NHS

February 1, 2018
Sales and Marketing Perjeta, Roche, biotech, drugs, pharma, pharmaceutical

NICE has given the nod to Roche’s Perjeta for routine first-line use, alongside Herceptin and chemotherapy, in patients with HER2-positive …

News
european_commission_web

EMA committee recommends seven therapies from Roche, GSK, MSD and more

January 29, 2018
Sales and Marketing Biocon, Chiesi, Chugai, GSK, GlaxoSmithKline, MSD, Mylan, Roche, Sanofi, pharma

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …

News
shutterstock_273326141

Abcam acquires rights to over 700 Roche products in new licensing deal

January 22, 2018
Sales and Marketing Abcam, Roche, partnership, pharma

Roche has entered a licensing agreement Abcam which gives the British biotech exclusive access to the marketing rights for 760 …

News
roche_close

Roche’s Ocrevus gets the go ahead in Europe for two forms of MS

January 12, 2018
Medical Communications, Sales and Marketing Europe, European Commission, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the …

News

Roche boosts oncology portfolio with $1.7bn acquisition

December 22, 2017
Medical Communications, Sales and Marketing Roche, biotech, drugs, ignyta, pharma, pharmaceutical

Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for …

News
roche

FDA grants breast cancer approval to Roche’s Perjeta/Herceptin combo therapy

December 21, 2017
Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma

Roche has announced that the FDA has granted approval to Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and a (Perjeta-based) …

News
fullsizerender_2_rav

Working Life: Dr Rav Seeruthun, Medical Director of Roche UK

December 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …

Feature
brainss

Ionis scores huge breakthrough in Huntington’s, Roche licenses drug

December 12, 2017
Manufacturing and Production, Research and Development Ionis, Roche, biotech, drugs, pharma, pharmaceutical

Ionis Pharmaceuticals has revealed findings from its Phase 1/2a study into a treatment for Huntington’s disease and the strong data …

News
roche_close

Roche Tecentriq combo effective, but is it enough?

December 8, 2017
Medical Communications, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …

News
roche__tree

Roche’s haemophilia A drug shows meaningful bleed control in P3

December 7, 2017
Research and Development Roche, haemophilia, pharma

Roche has unveiled new Phase 3 data for its haemophilia A treatment Helimbra (emicizumab) in patients over 12 years of …

News
fdaoutsideweb

Mylan’s Ogivri becomes first and only FDA-approved Herceptin biosimilar

December 4, 2017
Sales and Marketing Biocon, Cancer, FDA, Herceptin, Mylan, Roche, biosimilar, pharma

The FDA has announced the approval of Mylan’s Ogivri (trastuzumab-dkst), the first biosimilar version of Roche’s Herceptin to be authorised …

News
The Gateway to Local Adoption Series

Latest content

Teva announces positive results from trial of AJOVY for migraine

December 5, 2025

Vetter announces leadership transition as Thomas Otto retires

December 5, 2025

Samsung Bioepis announces launch of two new denosumab biosimilars in Europe

December 4, 2025

Medicus Pharma appoints Carolyn Bonner as CFO

December 4, 2025

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025